abuse liability assessment of the JUUL system in four flavors relative to combustible cigarette, nicotine gum and a comparator electronic nicotine delivery system among adult smokers.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Goldenson (2020)
an Open-Label, Randomized, Controlled, Crossover Study to assess Nicotine Pharmacokinetics and Subjective Effects of the JUUL System with Three Nicotine Concentrations Relative to Combustible Cigarettes in adult Smokers.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Goldenson (2021)
Differences in Switching Away From Smoking Among Adult Smokers Using JUUL Products in Regions With Different Maximum Nicotine Concentrations: North America and the United Kingdom.
Population Clinical
Likelihood Of Use
Former Smokers Switching To ENDS
Goldenson (2021)
Switching away from Cigarettes across 12 Months among Adult Smokers Purchasing the JUUL System.
Population Clinical
Likelihood Of Use
Former Smokers Switching To ENDS
Goldenson (2021)
Differences in switching away from cigarettes and JUUL use characteristics among adult menthol and nonmenthol smokers who purchased the JUUL System.
Population Clinical
Likelihood Of Use
Former Smokers Switching To ENDS
Goldenson (2022)